HealthSouth Corporation (HLS) Earns Buy Rating from Analysts at Craig Hallum

Craig Hallum began coverage on shares of HealthSouth Corporation (NYSE:HLS) in a report published on Monday morning. The brokerage issued a buy rating and a $48.00 price objective on the stock.

Other equities analysts have also issued reports about the company. RBC Capital Markets restated a buy rating and issued a $48.00 target price on shares of HealthSouth Corporation in a research note on Tuesday, January 3rd. Piper Jaffray Companies initiated coverage on HealthSouth Corporation in a research note on Tuesday, January 3rd. They issued a neutral rating and a $45.00 target price on the stock. Zacks Investment Research upgraded HealthSouth Corporation from a hold rating to a buy rating and set a $45.00 target price on the stock in a research note on Monday, October 31st. Mizuho lowered HealthSouth Corporation from a buy rating to a neutral rating in a research note on Wednesday, November 9th. Finally, Royal Bank Of Canada upped their target price on HealthSouth Corporation from $46.00 to $48.00 and gave the stock an outperform rating in a research note on Monday, October 31st. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the stock. HealthSouth Corporation currently has an average rating of Buy and an average price target of $46.78.

Shares of HealthSouth Corporation (NYSE:HLS) traded up 0.37% during midday trading on Monday, reaching $40.52. The company’s stock had a trading volume of 501,891 shares. HealthSouth Corporation has a one year low of $30.26 and a one year high of $43.38. The stock has a market cap of $3.64 billion, a PE ratio of 16.89 and a beta of 0.85. The firm has a 50-day moving average of $40.53 and a 200-day moving average of $40.76.

“HealthSouth Corporation (HLS) Earns Buy Rating from Analysts at Craig Hallum” was first published by sleekmoney and is the sole property of of sleekmoney. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of United States and international copyright legislation. The legal version of this news story can be accessed at http://sleekmoney.com/healthsouth-corporation-hls-earns-buy-rating-from-analysts-at-craig-hallum/1658807.html.

A number of institutional investors have recently bought and sold shares of the company. New York State Teachers Retirement System bought a new position in HealthSouth Corporation during the fourth quarter valued at about $664,000. Renaissance Technologies LLC raised its position in HealthSouth Corporation by 17.7% in the fourth quarter. Renaissance Technologies LLC now owns 386,900 shares of the company’s stock valued at $15,956,000 after buying an additional 58,200 shares during the last quarter. Cim Investment Mangement Inc. raised its position in HealthSouth Corporation by 2.2% in the fourth quarter. Cim Investment Mangement Inc. now owns 11,291 shares of the company’s stock valued at $466,000 after buying an additional 245 shares during the last quarter. Pacad Investment Ltd. raised its position in HealthSouth Corporation by 115.8% in the fourth quarter. Pacad Investment Ltd. now owns 4,100 shares of the company’s stock valued at $169,000 after buying an additional 2,200 shares during the last quarter. Finally, Credit Agricole S A raised its position in HealthSouth Corporation by 2.8% in the fourth quarter. Credit Agricole S A now owns 279,506 shares of the company’s stock valued at $11,527,000 after buying an additional 7,545 shares during the last quarter. Institutional investors and hedge funds own 98.89% of the company’s stock.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.

5 Day Chart for NYSE:HLS

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/healthsouth-corporation-hls-earns-buy-rating-from-analysts-at-craig-hallum/1658807.html

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *